Medline Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	29,140	28,432	25,507	23,231	21,448
Revenue Growth (YoY)	12.07%	11.47%	9.80%	8.31%	-
Cost of Revenue	21,605	20,914	18,531	17,346	16,231
Gross Profit	7,535	7,518	6,976	5,885	5,217
Selling, General & Admin	4,682	4,524	4,108	3,867	3,676
Depreciation & Amortization Expenses	705	704	685	662	660
Other Operating Expenses	85	78	37	106	20
Total Operating Expenses	5,472	5,306	4,830	4,635	4,356
Operating Income	2,063	2,212	2,146	1,250	861
Total Non-Operating Income (Expense)	-862	-964	-900	-986	-851
Pretax Income	1,201	1,248	1,246	264	10
Provision for Income Taxes	127	91	46	30	35
Net Income	964	1,159	1,200	234	-25
Minority Interest in Earnings	110	-2	-	-	-
Net Income to Common	964	1,159	1,200	234	-25
Net Income Growth	-21.43%	-3.42%	412.82%	-	-
Shares Outstanding (Basic)	846	810	-	-	-
Shares Outstanding (Diluted)	846	810	-	-	-
EPS (Basic)	0.15	-0.01	-	-	-
EPS (Diluted)	0.15	-0.01	-	-	-
Shares Outstanding	846	812	-	-	-
Free Cash Flow	1,029	1,297	1,415	1,410	-67
Free Cash Flow Growth	-20.66%	-8.34%	0.36%	-	-
Free Cash Flow Per Share	1.22	1.60	-	-	-
Gross Margin	25.86%	26.44%	27.35%	25.33%	24.32%
Operating Margin	7.08%	7.78%	8.41%	5.38%	4.01%
Profit Margin	3.69%	4.07%	4.70%	1.01%	-0.12%
FCF Margin	3.53%	4.56%	5.55%	6.07%	-0.31%
EBITDA	3,081	3,223	3,123	2,201	1,794
EBITDA Margin	10.57%	11.34%	12.24%	9.47%	8.36%
EBIT	2,063	2,212	2,146	1,250	861
EBIT Margin	7.08%	7.78%	8.41%	5.38%	4.01%
Effective Tax Rate	10.57%	7.29%	3.69%	11.36%	350.00%

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q